Filing Details
- Accession Number:
- 0001004878-18-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-15 14:21:23
- Reporting Period:
- 2018-02-12
- Accepted Time:
- 2018-02-15 14:21:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1436161 | United Cannabis Corp | CNAB | Pharmaceutical Preparations (2834) | 261391338 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604607 | Tony Verzura | 301 Commercial Rd. Golden CO 80401 | Vice President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-02-12 | 6,100 | $1.22 | 13,488,192 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-12 | 15,000 | $1.22 | 13,433,192 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-12 | 10,000 | $1.21 | 13,423,192 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-12 | 14,636 | $1.19 | 13,408,556 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-12 | 14,544 | $1.18 | 13,394,012 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-12 | 20,000 | $1.18 | 13,374,012 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-12 | 13,337 | $1.17 | 13,360,675 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-13 | 33,248 | $1.14 | 13,327,427 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-14 | 45,000 | $1.10 | 13,282,427 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |